Who
John Irving Bell
Director
Company insider
Files Form 4 as: Director, Immunocore Holdings.
In numbers
- Trades disclosed
- 4
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 1
- First trade
- 23 May 2024
- Last trade
- 27 May 2026
- Last filed
- 28 May 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 27 May 2026filed 28 May 2026 | IMCR Immunocore Holdingsoption or derivative · Biotechnology | SEC FORM 4 Code A | —27,492 at $0.00 | filing |
| 27 May 2026filed 28 May 2026 | IMCR Immunocore Holdingsoption or derivative · Biotechnology | SEC FORM 4 Code A | —27,492 at $0.00 | filing |
| 15 May 2025filed 19 May 2025 | IMCR Immunocore Holdingsoption or derivative · Biotechnology | SEC FORM 4 Code A | —26,198 at $0.00 | filing |
| 23 May 2024filed 28 May 2024 | IMCR Immunocore Holdingsoption or derivative · Biotechnology | SEC FORM 4 Code A | —14,534 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
No trade we could place in a sector.